News FDA accepts review of SeresTx BLA for oral microbiome therap... The FDA has accepted for review Seres Therapeutics’ Biologics License Application (BLA) for SER-109, an investigational oral
Events Partner Content 6th Microbiome Movement - Drug Development Summit Europe New generation of microbiome-targeted therapeutics
News Nestle gets closer to Seres, pledging $525m for microbiome C... Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million upfront for North American co-marketing rights to its lead drug for
Events Partner Content 6th Microbiome Movement - Drug Development Summit Discover the Next Generation of Microbiome Therapeutics
Events Partner Content 3rd Microbiome Movement – Maternal & Infant Health Summit Treatment creation for maternal and infant microbiome
Events Partner Content 5th Microbiome Movement - Drug Development Summit Europe 202... Exploring European Advances in Translational Microbiome
News Most pharmas not ready for AI in customer engagement Pharma wants to use AI for digital engagement with healthcare professionals and patients, but most feel unprepared to forge ahead, says survey.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
